Real-World Evidence Case Studies in AI/ML and Healthcare
Real-World Evidence Case Studies in AI/ML and Healthcare
This series examines real-world evidence through concrete case studies in emerging healthcare AI/ML applications.
Rather than approaching RWE only as an abstract methodological topic, this series uses contemporary examples to show how real-world data, observational systems, synthetic data, digital twins, remote monitoring, and AI-enabled operational workflows are already shaping evidence generation in healthcare.
The purpose is to study not only what these systems do, but also what kinds of evidence they produce, what assumptions they rely on, and how they expand or complicate the meaning of real-world evidence in modern healthcare analytics.
Topics in This Series
This series includes case studies such as:
- Duke Health Digital Twins for Cancer and Cardiovascular Disease
- Manchester University NHS Foundation Trust Digital Twin for Hospital Facilities
- Pfizer and IBM Project BlueSky Digital Twin for Remote Monitoring
- CDC National Center for Health Statistics Synthetic Data for Mortality Files
- Washington University School of Medicine Synthetic EHR for COVID-19 Tools
- UK Biobank Synthetic Data for Lung Cancer Risk Prediction
- OpenAI GPT-4o for Synthetic Perioperative Clinical Data
- GPT-2 for Synthetic EEG/EMG Signals in Biological Research
- Tempus TIME Trial Network AI for Oncology Patient Matching
- IQVIA AI for Consumer Health R&D and RWE
What This Series Is For
This series is intended for readers who want to understand how real-world evidence is evolving in practice through AI/ML-enabled systems rather than only through traditional observational study designs.
It is especially useful for:
- applied statisticians and epidemiologists
- healthcare AI/ML readers looking for real case examples
- analysts interested in digital twins and synthetic data
- registry and interoperability leaders
- readers who want to connect emerging technologies to evidence generation
How to Read This Series
A useful way to read this series is by thematic cluster.
Digital twins and simulation-based evidence
- Duke Health Digital Twins for Cancer and Cardiovascular Disease
- Manchester University NHS Foundation Trust Digital Twin for Hospital Facilities
- Pfizer and IBM Project BlueSky Digital Twin for Remote Monitoring
These cases show how digital twins can support personalized simulation, operational optimization, and real-time monitoring from clinical and sensor-linked data.
Synthetic data and privacy-preserving evidence generation
- CDC National Center for Health Statistics Synthetic Data for Mortality Files
- Washington University School of Medicine Synthetic EHR for COVID-19 Tools
- UK Biobank Synthetic Data for Lung Cancer Risk Prediction
- OpenAI GPT-4o for Synthetic Perioperative Clinical Data
- GPT-2 for Synthetic EEG/EMG Signals in Biological Research
These cases explore how synthetic data methods can preserve privacy, improve robustness, expand training data, and support analysis when direct access to patient-level data is limited. :contentReferenceoaicite:1
AI-enabled matching, protocol support, and evidence workflows
- Tempus TIME Trial Network AI for Oncology Patient Matching
- IQVIA AI for Consumer Health R&D and RWE
These cases show how AI can affect recruitment, protocol design, and evidence generation in real operational environments. :contentReferenceoaicite:2
Why This Series Matters
Real-world evidence is changing.
It no longer refers only to retrospective claims analyses or conventional registry-based observational studies. Increasingly, RWE is being shaped by:
- digital twins
- synthetic datasets
- sensor streams
- hybrid AI systems
- trial-matching platforms
- operational analytics embedded in care systems
These developments raise important questions:
- What counts as real-world evidence when simulation and synthetic data enter the workflow?
- How should privacy-preserving synthetic data be evaluated for fidelity and utility?
- When do digital twins complement observational evidence, and when do they introduce new uncertainty?
- How do AI-enabled operational systems reshape recruitment, matching, and evidence generation?
- What standards of validity should apply to emerging RWE architectures?
This series is about those questions.
Relationship to the Broader Blog
This series connects closely with several others across the site.
It pairs especially well with:
Where to Go Next
Readers who complete this series may want to continue with:
- Advanced Topics in Applied Statistics for AI and Clinical Decision-Making
- Toolkit
- Observational Medical Outcomes Partnership Common Data Model applied to a Trauma Registry
Return to the Series Hub.